Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Miners power Footsie gains

Mon, 09th Nov 2009 16:31

Mining stocks were at the vanguard of a strong advance from FTSE 100 as commodity prices were boosted by plans outlined by world leaders over the weekend to continue with stimulus measures.Kazakhmys, Fresnillo, Rio Tinto and Vedanta were some of the best performers in the mining sector.Mining giant Anglo American has added former Sainsbury chairman, Sir Philip Hampton, to the board in a non-executive role. Hampton has been chairman of Royal Bank of Scotland (RBS) since February 2009. After all the waiting and speculation, the formal bid for Cadbury from US group Kraft Foods proved a disappointment.Kraft formally announced a bid for Cadbury on the same terms as the indicative offer announced at the beginning of September. Not surprisingly, the Cadbury board gave the offer short shrift, noting that the terms of 300p cash plus 0.2589 Kraft Foods shares for every Cadbury share actually value each Cadbury share at a lower value now than when the bid terms were first mooted, thanks to the slide in Kraft's share price in the intervening weeks. Cadbury shares initially tumbled from just below 770p to just below 745p on the announcement of the bid terms but later moved back into the blue. The Kraft terms value each Cadbury share at 717p based on Friday's closing share price for Kraft.Prudential went well in a buoyant insurance sector after ING upped its price target for the stock from 392p to 584p.Cash-strapped bank Royal Bank of Scotland is also in demand after week-end analysis of last week's results and government asset protection scheme announcement.Inmarsat was on a high after the satellite operator lifted profits by nearly a third over the past three months. Revenue overall in the three months to September rose by 8.7% to $176.7m (2008: $162.5m). Profit before tax rose by 31% to $70m. Free cash flow rose 6% to $102.9m (2008: $54.0m).Fellow Footsie stock G4S fell, however, after it said things have been steady at the security services firm since August's interims. Operating profit for the first nine months of 2009 was up 25% at actual exchange rates and revenue rose by 23%. At constant exchange rates, profit rose 12% and revenue by 9%.Insurer and reinsurer Beazley has seen strong growth in premiums written this year, even after it pushed through rate increases. Gross premiums written in the first nine months of 2009 rose 45% to £861.9m from £595.4m in the first nine months of last year.Hiscox was in confident mood after boosting premium income by 31.7% in the first nine months of 2009, giving the specialist insurer "good reasons to be optimistic".Sales slumped further at Aer Lingus over the past three months with revenue down by nearly 10% as fares came under heavy pressure both on short-haul and long-haul flights.Oil and gas production levels were both higher in the third quarter at energy company JKX Oil and Gas. Total production in the third quarter of 2009 rose to 13,657 barrels of oil equivalent per day (boepd), up 24% from 10,978 boepd in the same period of 2008.Metal basher IMI has made a thumping gain after saying it expects earnings this year to come in " materially higher" than previously forecast as higher margins have offset a sharp fall in revenues.Shares in online poker giant PartyGaming have come up trumps following the group's purchase of the owner of the World Poker Tour brand. The company has paid £12.3m in cash for WPT Enterprises. Engineering and construction group Costain has been appointed to assist with a roadworks programme in the Midlands arising from the government's fiscal stimulus plan.The share price of respiratory disease drug developer Synairgen more than doubled in early trading on Monday after lab test suggested its inhaled interferon beta product could combat swine flu.FTSE 100 - RisersRoyal Bank of Scotland Group (RBS) 39.40p +6.30%Kazakhmys (KAZ) 1,286.00p +6.02%Prudential (PRU) 608.00p +5.19%Xstrata (XTA) 1,011.00p +5.04%Antofagasta (ANTO) 893.00p +4.63%Vedanta Resources (VED) 2,367.00p +4.60%Inmarsat (ISAT) 621.00p +4.46%Fresnillo (FRES) 875.00p +4.35%Legal & General Group (LGEN) 83.25p +4.32%Rio Tinto (RIO) 3,042.00p +4.29%FTSE 100 - FallersCable & Wireless (CW.) 136.80p -1.58%G4S (GFS) 249.90p -1.15%Next (NXT) 1,967.00p -0.41%WPP Group (WPP) 568.50p +0.09%Severn Trent (SVT) 946.50p +0.11%SEGRO (SGRO) 346.30p +0.14%Capita Group (CPI) 768.50p +0.20%British American Tobacco (BATS) 1,963.00p +0.20%Tesco (TSCO) 418.85p +0.20%British Airways (BAY) 199.30p +0.25%FTSE 250 - RisersIMI (IMI) 529.50p +15.16%Yell Group (YELL) 48.00p +8.72%Punch Taverns (PUB) 93.50p +6.13%Cookson Group (CKSN) 393.60p +5.52%Ferrexpo (FXPO) 168.20p +4.99%Dunelm Group (DNLM) 390.00p +4.64%Bodycote (BOY) 172.50p +4.61%Chloride Group (CHLD) 173.50p +4.58%Talvivaara Mining Company (TALV) 380.30p +4.45%Petropavlovsk (POG) 1,284.00p +4.39%FTSE 250 - FallersForth Ports (FPT) 1,135.00p -4.46%Fidessa (FDSA) 1,217.00p -3.11%Filtrona PLC (FLTR) 174.50p -3.06%Berkeley Group Holdings Units (BKG) 831.00p -2.86%Stobart Group (STOB) 124.50p -2.73%Cranswick (CWK) 680.50p -2.23%Genus (GNS) 634.50p -2.08%Go-Ahead Group (GOG) 1,365.00p -1.87%Avis Europe (AVE) 25.93p -1.78%Morgan Sindall (MGNS) 550.50p -1.70%
More News
5 Sep 2022 10:42

Synairgen to collaborate with University of Southampton on observational study

(Sharecast News) - Drug discovery outfit Synairgen will collaborate with the University of Southampton on an observational study aimed at exploring and better understanding acute respiratory viral infections and recovery.

Read more
23 Jun 2022 16:02

UK shareholder meetings calendar - next 7 days

Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
Wednesday 29 June 
Africa Opportunity Fund LtdAGM
Argo Blockchain PLCAGM
Atome Energy PLCAGM
Brave Bison Group PLCAGM
Concurrent Technologies PLCAGM
Eden Research PLCAGM
Facilities by ADF PLCAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Hurricane Energy PLCAGM
i(x) Net Zero PLCAGM
Lords Group Trading PLCAGM
MaxCyte IncAGM
Meggitt PLCAGM
Mobile Tornado Group PLCAGM
NB Distressed Debt Investment Fund LtdAGM
NetScientific PLCAGM
Provident Financial PLCAGM
RA International Group PLCAGM
Reabold Resources PLCAGM
Symphony Environmental Technologies PLCAGM
Team17 Group PLCAGM
ThinkSmart LtdGM re approval for capital return
Trinity Exploration & Production PLCAGM
URA Holdings PLCAGM
XP Factory PLCAGM
Zaim Credit Systems PLCAGM
Thursday 30 June 
3i Group PLCAGM
Ashtead Technology Holdings PLCAGM
Borders & Southern Petroleum PLCAGM
Caspian Sunrise PLCAGM
Cobra Resources PLCAGM
Crimson Tide PLCAGM
ECSC Group PLCAGM
Evraz PLCAGM
Gresham House Energy Storage Fund PLCAGM
GRIT Investment Trust PLCAGM
Gulf Marine Services PLCAGM
Hamak Gold LtdAGM
Hemogenyx Pharmaceuticals PLCAGM
Immotion Group PLCAGM
Inspiration Healthcare Group PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kropz PLCAGM
Likewise Group PLCAGM
Live Co Group PLCAGM
Location Sciences Group PLCAGM
LoopUp Group PLCAGM
M&C Saatchi PLCAGM
Microsaic Systems PLCAGM
Nostra Terra Oil & Gas CoAGM
Pathfinder Minerals PLCAGM
Playtech PLCAGM
Primorus Investments PLCAGM
Rockfire Resources PLCAGM
Roquefort Therapeutics PLCAGM
Sanne Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
Supply@ME Capital PLCAGM
Surface Transforms PLCAGM
Synairgen PLCAGM
Tower Resources PLCAGM
Trainline PLCAGM
ValiRx PLCAGM
Victoria Oil & Gas PLCAGM
Watchstone Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 May 2022 12:00

IN BRIEF: Synairgen shares fall as loss widens on higher costs

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Records a pretax loss of GBP57.9 million in 2021, widened from GBP17.7 million in 2020, as research and development costs jump to GBP52.9 million from GBP15.5 million. Further, administrative expenses more than double to GBP5.0 million from GBP2.2 million. Explains this with its phase 3 Sprinter trial that started patient recruitment in January 2021. The trial is for SNG001, an inhaled drug for the treatment of Covid-19. Says the remainder of the research and development expenditure was used for upscaling SNG001 manufacturing development activities and procuring long lead time components.

Read more
16 May 2022 15:23

Synairgen posts positive clinical trial data for SNG001

(Sharecast News) - Shares of Synairgen caught a bid following the release of clinical trial results which appeared to show that its SNG001 formulation against Covid-19 might lower the risk of severe disease or death in the most at risk patients.

Read more
16 May 2022 12:18

LONDON MARKET MIDDAY: FTSE 100 edges into green but grey clouds remain

(Alliance News) - The FTSE 100 index put a toe into positive territory by midday on Monday, reclaiming all the ground lost earlier in the morning, but investors continue to fret about poor economic data from China.

Read more
16 May 2022 12:18

IN BRIEF: Synairgen shares soar on positive analysis of SNG001

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Notes that it announced in February that its phase 3 Sprinter trial did not meet its primary endpoints of discharge from hospital and recovery. Says that the trial still showed an encouraging signal in the reduction in the relative risk of progression to severe disease or death within 35 days. Says that it performed a post hoc analysis on groups of patients recognised to be at greater risk of developing severe disease in hospital, to assess the strength of this signal. Says that the analyses showed stronger treatment effects with SNG001 in high-risk patient sub-groups, with the strongest effect observed in those who had clinical signs of compromised respiratory function. Says SNG001 significantly reduced the risk of progression to severe disease and death compared to a placebo by 70% in the per-protocol population.

Read more
17 Mar 2022 12:32

Synairgen falls as patient recruitment halted on Covid-19 trial

(Sharecast News) - Inhaled antiviral treatment developer Synairgen said on Thursday that the US National Institute of Allergy and Infectious Diseases (NIAID) has halted all patient recruitment in its phase 2 and 3 Covid-19 trial, which included the assessment of its 'SNG001' treatment.

Read more
17 Mar 2022 11:48

IN BRIEF: Synairgen falls as patient recruitment in US trial halted

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Says the US National Institute of Allergy & Infectious Diseases has halted all patient recruitment in its phase 2/3 Covid-19 trial. The trial included the assessment of its inhaled SNG001 drug.

Read more
17 Mar 2022 11:21

AIM WINNERS & LOSERS: Synairgen sinks 18% after US Covid study halted

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
3 Mar 2022 20:34

TRADING UPDATES: Next Fifteen raises GBP50 million; N Brown sales up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 Mar 2022 12:20

Synairgen asked to pause activities on Covid-19 treatment trial

(Sharecast News) - Synairgen announced on Thursday that it was pausing clinical trial activities on its 'SNG001' compound in the treatment of Covid-19, at the behest of American authorities.

Read more
3 Mar 2022 11:29

AIM WINNERS & LOSERS: dotDigital plunges after profit warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
21 Feb 2022 12:25

Synairgen falls as trial for Covid treatment fails to meet endpoints

(Alliance News) - Synairgen PLC shares hit a 12-month low on Monday after the biotechnology company said that the late-stage trial of its Covid-19 treatment SNG001 did not meet primary or key secondary efficacy endpoints.

Read more
21 Feb 2022 11:33

AIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Feb 2022 09:27

Synairgen shares plunge as Covid-19 treatment trial fails

(Sharecast News) - Synairgen announced on Monday that the international phase 3 trial of its SNG001 antiviral inhalation in patients hospitalised with Covid-19 did not meet its primary or key secondary endpoints.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.